These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 22377746
1. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients. Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, Peng ZH, Liu GL. Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746 [Abstract] [Full Text] [Related]
2. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Staatz CE, Willis C, Taylor PJ, Tett SE. Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747 [Abstract] [Full Text] [Related]
3. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE. Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506 [Abstract] [Full Text] [Related]
4. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. Staatz CE, Tett SE. Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452 [Abstract] [Full Text] [Related]
5. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant]. Xue L, Rui JZ, Zhang Y, Miao LY. Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140 [Abstract] [Full Text] [Related]
6. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Sam WJ, Tham LS, Holmes MJ, Aw M, Quak SH, Lee KH, Lim SG, Prabhakaran K, Chan SY, Ho PC. Clin Pharmacokinet; 2006 Oct; 45(1):59-75. PubMed ID: 16430311 [Abstract] [Full Text] [Related]
7. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations. Vadcharavivad S, Praisuwan S, Techawathanawanna N, Treyaprasert W, Avihingsanon Y. J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538 [Abstract] [Full Text] [Related]
8. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients. Jacobson P, Ng J, Ratanatharathorn V, Uberti J, Brundage RC. Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626 [Abstract] [Full Text] [Related]
9. Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose. Bergmann TK, Hennig S, Barraclough KA, Isbel NM, Staatz CE. Ther Drug Monit; 2014 Feb; 36(1):62-70. PubMed ID: 24089074 [Abstract] [Full Text] [Related]
10. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K. Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564 [Abstract] [Full Text] [Related]
11. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. Press RR, Ploeger BA, den Hartigh J, van der Straaten T, van Pelt J, Danhof M, de Fijter JW, Guchelaar HJ. Ther Drug Monit; 2009 Apr; 31(2):187-97. PubMed ID: 19258929 [Abstract] [Full Text] [Related]
12. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients. Zahir H, McLachlan AJ, Nelson A, McCaughan G, Gleeson M, Akhlaghi F. Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097 [Abstract] [Full Text] [Related]
13. Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation. Musuamba FT, Guy-Viterbo V, Reding R, Verbeeck RK, Wallemacq P. Ther Drug Monit; 2014 Feb; 36(1):54-61. PubMed ID: 24081207 [Abstract] [Full Text] [Related]
14. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study. Musuamba FT, Mourad M, Haufroid V, Delattre IK, Verbeeck RK, Wallemacq P. Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314 [Abstract] [Full Text] [Related]
15. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance. Wallin JE, Bergstrand M, Wilczek HE, Nydert PS, Karlsson MO, Staatz CE. Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583 [Abstract] [Full Text] [Related]
16. Impact of Donor and Recipient CYP3A5*3 Genotype on Tacrolimus Population Pharmacokinetics in Chinese Adult Liver Transplant Recipients. Shao J, Wang C, Fu P, Chen F, Zhang Y, Wei J. Ann Pharmacother; 2020 Jul; 54(7):652-661. PubMed ID: 31888346 [Abstract] [Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period. Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A. Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556 [Abstract] [Full Text] [Related]
18. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients]. Zhang GM, Li L, Chen WQ, Bi SS, Liu X, Zhang XL, Lu W. Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472 [Abstract] [Full Text] [Related]
20. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients. Minematsu T, Sugiyama E, Kusama M, Hori S, Yamada Y, Ohtani H, Sawada Y, Sato H, Takayama T, Sugawara Y, Makuuchi M, Iga T. Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]